• 1-240-425-7688
  • info@bla-regulatory.com
logo
  • Services
    • Biopharmaceutical Consulting
      • Gap Analysis
      • Health Authority Meetings
      • IND Filing & Maintenance
      • Leading PI Recruitment
      • U.S. Agent Representation
      • Clinical Trials Registration
      • Strategy Development
      • Medical Writing
      • BLA, NDA Filing & Maintenance
      • Global Regulatory Reach
      • eCTD Publishing & Submission
      • Expedited Regulatory Programs
    • Medical Device Consulting
      • Medical Device Applications
      • Medical Device Reimbursement Services
    • Business Development Consulting
  • Consultants
  • About Us
    • About Us
    • FAQ
    • Career
  • Insights
    • Regulatory Intelligence
      • Weekly PharmaFocus
      • Monthly MedTech Orbit
      • Quarterly PharmaSphere
    • News
    • Events
    • Webinars
  • Contact

Home
no image found

2026 User Fees Update! US FDA, EMA, and PMDA

...
Yuka Osada No Comments
no image found
fda-human-factors-engineering-devices

Why US FDA Demands Human Factors Engineering for Devices?

...
Yuka Osada No Comments
no image found
Ready for US-FDA E2B(R3) Safety Reporting from April 1st

Ready for US-FDA E2B(R3) Safety Reporting from April 1st?

...
Yuka Osada No Comments
no image found
Evidence Is the Product – Rethinking U.S FDA Device Testing

Evidence Is the Product – Rethinking U.S FDA Device Testing

...
Yuka Osada No Comments
no image found
Are U.S. FDA Regulatory Consultants Required in this AI-Era

Are U.S. FDA Regulatory Consultants Required in this AI-Era?

...
Yuka Osada No Comments
no image found
Close-up of a human eye reflecting a colorful horizon, symbolizing the future of ophthalmic therapies and the evolving $79.4B eye-care landscape

Eye on the Horizon: The $79B Evolution of Ophthalmic Therapies

...
Yuka Osada No Comments
no image found
Illustration of FDA CRL transparency and drug sponsor strategy.

The ‘Black Box’ Opens: FDA’s Public Release of Complete Response Letters Explained

...
Yuka Osada No Comments
no image found

Snapshot of FDA CDER IND Activity 2024-25

...
Yuka Osada No Comments
no image found
symbolizing drug shortage management and regulatory oversight

U.S. vs. Foreign Sponsors: Who Really Manages Drug Shortages?

...
Yuka Osada No Comments
no image found
US FDA headquarters with official seal – symbol of drug approval authority

Snapshot of US FDA Drug Approval Trends 2024 – 25

...
Yuka Osada No Comments
1 2 3 Next Page »

Join Our Newsletter
  Thank you for Signing Up
Please correct the marked field(s) below.
1,true,6,Contact Email,21,false,1,First Name,21,false,1,Last Name,2

 

610 Professional Dr. Suite 225
Gaithersburg, MD 20879

1-240-425-7668
info@bla-regulatory.com

© 2026 BLA Regulatory. All Rights Reserved.

Privacy Policy | Terms & Conditions

Website designed and maintained by USABAL Solutions